| Mitochondrial glutathione, a key survival antioxidant | Antioxidants and Redox Signaling | 2009 | 648 |
| Renal failure in cirrhosis | New England Journal of Medicine | 2009 | 571 |
| Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma | Gastroenterology | 2009 | 483 |
| Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease | Gut | 2009 | 469 |
| Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins | FASEB Journal | 2009 | 448 |
| A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma | Gastroenterology | 2009 | 377 |
| Bile acids: chemistry, physiology, and pathophysiology | World Journal of Gastroenterology | 2009 | 336 |
| Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities | EMBO Reports | 2009 | 319 |
| Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial | Gastroenterology | 2009 | 288 |
| miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments | Nucleic Acids Research | 2009 | 244 |
| Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats | Hepatology | 2009 | 232 |
| Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex | Hepatology | 2009 | 221 |
| Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect | Oncogene | 2009 | 221 |
| Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study | American Journal of Transplantation | 2009 | 210 |
| Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma | Hepatology | 2009 | 207 |
| A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer | Annals of Oncology | 2009 | 205 |
| Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy | Gastroenterology | 2009 | 197 |
| Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo | Journal of Hepatology | 2009 | 182 |
| A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma | Nature Biotechnology | 2009 | 173 |
| The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status | European Journal of Cancer | 2009 | 153 |
| Anemia and inflammatory bowel diseases | World Journal of Gastroenterology | 2009 | 127 |
| Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications | Gastroenterology Clinics of North America | 2009 | 120 |
| Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity | Journal of Neuroscience | 2009 | 115 |
| Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin | Hepatology | 2009 | 110 |
| Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis | Clinical Gastroenterology and Hepatology | 2009 | 109 |
